| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Kohli Prashant serves as a Chief Executive Officer at GRCE. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $260K at current prices.
The biggest single holding is GRCE (~$260K) as Chief Executive Officer. Net of sales, the recent Form 4 record there shows accumulation of 100,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | GRCE Grace Therapeutics, Inc. | Chief Executive Officer | Buy | 100,000 | $2.14 | $214,000.00 | +468.2% | - | - |